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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S164more reactive cells, the mitochondrial signals showed a perinuclear
distribution.
Kinetic evaluation of the cells treated with LiCl across 8, 16, 24 , 48 and
72 hours showed that GSK3b inactivation impacts on cellular pro-
liferation, with evident reduction particularly at 24 hours post stim-
ulation. Noteworthy, cell cycle analysis consistently showed increased
percentage of cells in the S phase at this time point. The histochemical
SA-b Gal staining conﬁrmed that GSK3b inhibition increases cell sen-
escence, despite an already appreciable basal level, possibly due to the
osteoarthritic nature of the samples. Noteworthy, the cells showing
stronger level of SA-b galactosidase were larger than the other cells and
“hypertrophic”. The same information was achieved by PAS staining
that revealed a stronger content of glycogen in hypertrophic cells which
increased in samples treated with LiCl compared with the unstimulated
chondrocytes. Flow cytometric analysis conﬁrmed that larger cells
accumulated upon LiCl treatment, particularly in the S Phase, already at
8 hours stimulation, as evidenced by their increased forward scatter.
Collectively, following GSK3b inactivation, western blot and ﬂow cyto-
metric analysis supported the occurrence of a DNA damage response
leading to cellular senescence with increase in gH2AX, GADD45b and
p21.
Conclusions: We have found that GSK3b activity in OA chondrocytes is
essential for maintenance of their proliferative potential and that its
inactivation also appreciably affects the mitochondrial function, being
responsible for the production of reactive oxygen species. This in turn
triggers the induction of a DNA damage response via the axis
gH2AX>GADD45b> p21which leads to survival of chondrocytes but to
their functional impairment via induction of hypertrophy and
senescence.
Acknowledgement: This work was supported by FIRB (Ministero del-
l’Istruzione, dell’Universita e della Ricerca, Italy) grant RBAP10KCNS and
Fondi cinque per mille (Ministero della Salute,Italy)
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SPRIFERMIN (RHFGF18) HAS AN ANABOLIC EFFECT ON HUMAN
OSTEOARTHRITIC CHONDROCYTES INVOLVING FGFR3 AND ERK1/2
BUT NOT P38a AND JNKS
A. Gigout, S. Lindemann, H. Guehring. Merck Serono, Merck KGaA,
Darmstadt, Germany
Purpose: Restoring the articular surface of degraded or largely injured
cartilage necessitates cartilage re-cellularization and the stimulation of
cartilagematrix molecule production. Sprifermin (currently in a phase II
clinical trial for knee osteoarthritis) is a growth factor that is involved in
chondrogenesis and exerts an anabolic effect on cartilage. Using a 3D
cell culture system, we previously demonstrated the ability of Spri-
fermin to stimulate cartilage matrix molecule expression and to pro-
mote the chondrocyte phenotype in bovine and porcine articular
chondrocytes. In the present work, we aimed to conﬁrm this effect in
osteoarthritic chondrocytes of human origin (hOA). In parallel, the
pathways involved in Sprifermin signaling were investigated in porcine
chondrocytes.
Methods: Primary osteoarthritic chondrocytes were isolated from the
cartilage of patients who underwent total knee replacement. Cells were
cultivated for a few days in monolayer ﬁrst and then for one week in
scaffold-free 3D culture before starting the treatment. The latter con-
sisted in the incubation with Sprifermin [100 ng/mL] permanently or
one day/week for a total period of four weeks. Results were compared to
a control culture without Sprifermin. Biochemical assays, quantitative
PCR (qPCR) and histology were used to characterize the 3D constructs.
FGFR expression by qPCR and activation of various kinases (with the
human phospho-MAPK array kit from R&D Systems) upon Sprifermin
stimulation were assessed on freshly isolated hOA chondrocytes. The
effects of a panel of inhibitors (MAPK inhibitors and one pan-FGFR
inhibitor) were tested in porcine cells. For this, freshly isolated chon-
drocytes from a pig hip were cultivated for 7 days in monolayer with
100 ng/mL of Sprifermin in presence of three concentrations of the
inhibitors (0.1, 0.3 and 1 mM or 1, 3 and 10 mM depending on their
potency). Sprifermin has been previously shown to strongly decrease
the collagen I expression (monitored by qPCR) and to promote a round
cell morphology (evaluated by actin staining) of porcine chondrocytes
in monolayer. These parameters were used to evaluate the impact of the
various inhibitors.
Results: A 3D scaffold-free culture was used to test the effect of Spri-
fermin on hOA chondrocytes. In this setting Sprifermin [1day/week] hasbeen found to have a positive effect on the cell content and to greatly
increase the size and matrix content of the 3D constructs.
In accordance with the literature, FGFR1 and 3 exhibited the highest
expression among FGFRs in hOA chondrocytes. In addition, Sprifermin
effects were suppressed by FGFR inhibition. In porcine chondrocytes
cultivated in monolayer, Sprifermin strongly inhibited collagen I
expression and promoted a round cell shape. Both effects were com-
pletely inhibited in presence of the pan-FGFR inhibitor PD173074 in a
dose-dependent manner. Because FGF18 does not bind FGFR1, in
chondrocytes Sprifermin signaling involves mainly FGFR3.
Upon incubation with Sprifermin [100 ng/mL], ERK1/2 was activated as
well as p38g, but not p38a or the JNKs. The ERK inhibitor PD325901
completely inhibited the effect of Sprifermin on cell morphology at 100
nM. The JNK inhibitor (SR3306) and p38 inhibitors (BIRB-796 and
SB203580) did not have any effect. The effect of these inhibitors on
collagen I expression is still under investigation. Taken together these
results indicate that ERK1/2 is involved in Sprifermin signaling whereas
p38a and JNKs are not.
Conclusions: As observed in previous studies with bovine and porcine
chondrocytes, Sprifermin was found to exert anabolic effects in hOA
chondrocytes. These effects seem to be mediated by FGFR3 and ERK1/2
activation. Others demonstrated that ERK1/2 is also involved in FGF2-
FGFR1 signaling but in this case led to a catabolic response. This dif-
ference can be possibly explained by the fact that JNK and p38 are also
activated by FGF2-FGFR1 signaling but not by FGF18-FGFR3.
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HIF-1a REGULATES CONFIGURATION AND MAINTENANCE OF
ARTICULAR CARTILAGE THROUGH INDUCTION OF ANABOLIC
FACTORS AND SUPPRESSION OF CATABOLIC FACTORS
K. Okada y, Y. Hosaka y, H. Kobayashi y, S. Sugita y, S. Chang y, Y. Mori y,
H. Akiyama z, S. Tanaka y, H. Kawaguchi y,x, T. Saito k. y Sensory and
Motor System Med., Faculty of Med., Univ. of Tokyo, Tokyo, Japan;
zOrthopedic Surgery, Graduate Sch. of Med., Gifu Univ., Gifu, Japan;
x Spine Ctr., Tokyo Kosei Nenkin Hosp., Tokyo, Japan; kBone and
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Purpose: Hypoxia-inducible factor-1a (HIF-1a) plays a crucial role in
hypoxic conditions for cell survival in various tissues. In chondrocytes,
previous studies showed that HIF-1a was necessary for chondrocyte
survival in endochondral ossiﬁcation and for interzone formation in
joint development; however, the underlying molecular mechanisms
remain unclear. Moreover, physiological and pathological functions of
HIF-1a in articular cartilage are yet to be revealed. Here we have
investigated HIF-1a functions and the underlying mechanisms of the
conﬁguration and maintenance of articular cartilage by HIF-1a.
Methods: We generated tissue-speciﬁc knockout mice of HIF-1a by
mating Sox9-Cre knock-in mice (Sox9-Cre) or tamoxifen-inducible
Col2a1-Cre transgenic mice (Col2a1-CreERT2), with mice homozygous
for a ﬂoxed Hif1a allele (Hif1aﬂ/ﬂ). For analyses of cartilage conﬁg-
uration, we examined Sox9-Cre;Hif1aﬂ/ﬂmice at E15.5, E18.5 and P1. To
analyze articular cartilage maintenance and osteoarthritis (OA) pro-
gression after maturation, we injected tamoxifen into 7-week-old
Col2a1-CreERT2;Hif1aﬂ/ﬂ mice, and created a surgical OA model by
inducing instability in the knee joints one week later. OA severity was
quantiﬁed by the OARSI histopathology grade 8 weeks after surgery. For
histological analyses of these knockout mice, we performed Safranin O
staining, TUNEL staining, and immunoﬂuorescence. Quantitative gene
expression in limb cartilages of Sox9-Cre;Hif1aﬂ/ﬂ and the control
Hif1aﬂ/ﬂ neonates was determined based on real-time RT-PCR analyses
using samples obtained directly from their limb cartilages. To assess the
catabolic ability of HIF-1a, we measured the concentration of aggrecan
released from the 3-week-old mouse femoral heads cultured with or
without CoCl2, a potent enhancer of HIF-1a protein stability, utilizing
dimethylmethylene blue dye-binding assay. Mouse primary articular
chondrocytes were used for further in vitro functional analyses.
Results: Sox9-Cre;Hif1aﬂ/ﬂ embryos and neonates showed dwarﬁsm
with severe limb shortening throughout the embryonic stages and died
in the perinatal period. This phenotype was consistent with previous
reports using Prx1-Cre and Col2a1-Cre mice. Notably, the knee joints of
Sox9-Cre;Hif1aﬂ/ﬂ embryos showed a widespread epiphysis with a
massive cavity continuing from the joint surface forming a trumpet
shape, in which the columnar architecture was completely abolished
and the cell numbers were vastly reduced(Fig.1). Safranin O staining
* These authors contributed equally to this work
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S165showed a decrease in proteoglycan content in comparison with the
control Hif1aﬂ/ﬂ embryo. TUNEL staining accentuated ectopic apoptosis
broadly across the limb cartilage, and immunoﬂuorescence showed
enhanced expression of Mmp13 surrounding the defective area. When
we created the experimental OA model one week after the tamoxifen
injection into Col2a1-CreERT2;Hif1aﬂ/ﬂ mice, the OA development in
the knee joints was markedly accelerated as compared to the control
Hif1aﬂ/ﬂ joints. Apoptosis and Mmp13 expression were upregulated by
the conditional knockout of HIF-1a after maturation in articular carti-
lage, as well as in the limb cartilage. To reveal altered gene expression
by HIF-1a deﬁciency, we obtained RNA samples directly from the limb
cartilages of Sox9-Cre;Hif1aﬂ/ﬂ and the control Hif1aﬂ/f embryo. Real-
time RT-PCR using these samples revealed increases of catabolic factors
including Mmp13 and Mmp9, and decreases of anabolic factors
including Col2a1 and Sox9 by the conditional knockout of HIF-1a. When
we deleted HIF-1a in primary articular chondrocytes from Hif1aﬂ/ﬂ
mice by adenoviral vector expressing Cre recombinase, expressions of
the catabolic and the anabolic genes were changed in ways similar to
those in the in vivo analyses, under both normoxic and hypoxic (1% O2
concentration) conditions. Similar results were also obtained under
both O2 conditions by HIF-1a silencing in primary articular chon-
drocytes from WT mice using siRNA. Furthermore, in the organ culture
of mouse femoral heads, stabilizing HIF-1a protein by CoCl2 treatment
markedly decreased aggrecan release into the medium.
Conclusions: HIF-1a regulates the conﬁguration and maintenance of
articular cartilage through induction of anabolic factors and sup-
pression of catabolic factors. Elucidation of the molecular network
related to HIF-1amay lead to cartilage regeneration and OA treatment.
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DNA REPAIR ENZYME, APURINIC/APYRIMIDINIC ENDONUCLEASE 2
(APEX2), HAS A POTENTIAL TO PROTECT AGAINST THE DOWN-
REGULATION OF CONDROCYTE ACTIVITY IN OSTEOARTHRITIS
N. Yui y, K. Yudoh z, R. Karasawa z, H. Yoshioka y, H. Musha y. yDept. of
Sports Med., St.Marianna Univ. Sch. of Med., Kawasaki, Japan; z Inst. of
Med. Sci., St.Marianna Univ. Sch. of Med., Kawasaki, Japan
Background: Recent reports clearly indicate that chronic excess pro-
duction of reactive oxygen species (ROS) from chondrocytes, which is
induced by mechanical force to cartilage, plays an important role in
cartilage degeneration occurring after mechanical injury to cartilage in
osteoarthritis (OA). However, pathogenic mechanism of ROS-mediated
degeneration of articular cartilage remains unknown. While studies
have provided ample conﬁrmation of the generation of ROS in OA car-
tilage, the activity of cellular antioxidants in degenerated articular
cartilage still remains unclear.
Propose: Apurinic/apyrimidinic endonuclease 2 (Apex2) is an essential
DNA repair enzyme that plays a critical role in DNA repair against the
oxidative damage in a variety of human somatic cells. We postulated
that Apex2 in chondrocytes may have a role to protect against the
catabolic process of articular cartilage in OA. The aim of the studywas to
examine the potential involvement of DNA repair enzyme Apex2 in the
pathogenesis of OA.
Methods: Expression of Apex2 was histologically investigated in OA
articular cartilages from STR/OrtCrlj mice, an experimental animal
model which spontaneously develops an osteoarthritic process. We
examined whether OA-related catabolic factor [interleukin (IL)-1b]inﬂuenced the expressions of Apex2 in human chondrocytes. Knock-
down of Apex2 with small interfering RNA (siRNA) was also performed
to investigate whether Apex2 is associated with cellular activity and
survival in human chondrocytes.
Results: In OA mouse chondrocytes, higher levels of Apex2 expressions
were histologically observed in the severe OA cartilages than in mild
degenerated cartilages. The immunopositivity of Apex2 was sig-
niﬁcantly correlated with the degree of cartilage degeneration (Figure).
OA-related catabolic factor, IL-1b, induced the expression of Apex2 in
chondrocytes. Apex2 silencing using siRNA reduced the chondrocyte
activity in vitro.
Conclusions: The expression of DNA repair enzyme Apex2 in chon-
drocytes was associated with the degeneration of articular cartilages
and was induced by OA-relating catabolic factor. Our ﬁndings suggest
that Apex2 may have a potential to prevent the catabolic stress-medi-
ated down-regulation of chondrocyte activity in OA.
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HYPERGLYCEMIA-LIKE CULTURE CONDITIONS INDUCE IL-1B AND
TNF-a EXPRESSION AND IMPAIR AUTOPHAGY IN HUMAN
CHONDROCYTES
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Purpose: Accumulating evidence indicates that Diabetes Mellitus (DM)
is an independent risk factor for severe osteoarthritis (OA). Under-
standing the mechanisms involved is essential for designing preventive
strategies and targeted therapies that can halt OA progression in DM
patients. In this context, we hypothesized that hyperglycemia, a hall-
mark of DM and other conditions associated with glucose imbalance, is
a major effector of chondrocyte damage. Accordingly, our previous
studies showed that culture of human chondrocytes under excess glu-
cose favors catabolic responses and oxidative stress. This study aims at
further characterizing the effects of hyperglycemia in human chon-
drocytes by determining whether it also promotes inﬂammatory
responses. Furthermore and to gain some insight as to the mechanisms
by which hyperglycemia favors OA progression, modulation of
autophagy was also evaluated as a crucial mechanism for the elimi-
nation of damaged proteins and organelles whose impairment has been
implicated in the deleterious effects of hyperglycemia in various cells.
Methods: Articular cartilage was obtained from multi-organ donors
(44-73 years old, mean ¼ 59.4, n ¼ 10) at the Bone Bank of the Uni-
versity and Hospital Center of Coimbra with approval by the Ethics
Committee. Isolated chondrocytes and the human chondrocytic cell
line, C28/I2 (kindly provided by Prof. Mary Goldring and Harvard Uni-
versity), were cultured in Ham-F12 or DMEM:Ham F-12 (1:1), respec-
tively, containing regular (10 mM) or excess (30 mM) glucose for
various periods. The expression of pro-inﬂammatory markers (IL-1b
and TNF-a) was evaluated by qRT-PCR. Autophagy was assessed by
determining the protein levels of LC3-I and II in the presence and
absence of the lysosome inhibitor, chloroquine. To rule out possible
osmotic effects, parallel experiments were performed in the presence of
the cell-impermeable polyol, mannitol. Cell viability was evaluated by
the MTT reduction assay.
